Phosphorylation of tyrosine 393 in the kinase domain of Bcr-Abl influences the sensitivity towards imatinib in vivo. (Q40635025)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12970766 AND SRC:MED&resulttype=core&format=json

7 November 2019

title

Phosphorylation of tyrosine 393 in the kinase domain of Bcr-Abl influences the sensitivity towards imatinib in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12970766 AND SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12970766 AND SRC:MED&resulttype=core&format=json

7 November 2019

author name string

Mugler C

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12970766 AND SRC:MED&resulttype=core&format=json

7 November 2019

Grundler R

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12970766 AND SRC:MED&resulttype=core&format=json

7 November 2019

Hoepfl J

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12970766 AND SRC:MED&resulttype=core&format=json

7 November 2019

Bai RY

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12970766 AND SRC:MED&resulttype=core&format=json

7 November 2019

Peschel C

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12970766 AND SRC:MED&resulttype=core&format=json

7 November 2019

Duyster J

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12970766 AND SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12970766 AND SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12970766 AND SRC:MED&resulttype=core&format=json

7 November 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12970766 AND SRC:MED&resulttype=core&format=json

7 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12970766 AND SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

1695-1699

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12970766 AND SRC:MED&resulttype=core&format=json

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403040

A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403040

Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403040

Resistance of Philadelphia-chromosome positive leukemia towards the kinase inhibitor imatinib (STI571, Glivec): a targeted oncoprotein strikes back

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403040

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403040

The SH2-containing adapter protein GRB10 interacts with BCR-ABL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403040

Src homology 2 domain as a specificity determinant in the c-Abl-mediated tyrosine phosphorylation of the RNA polymerase II carboxyl-terminal repeated domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403040

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403040

Mechanisms of resistance imatinib (STI571) in preclinical models and in leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403040

BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403040

Phosphorylation and structure-based functional studies reveal a positive and a negative role for the activation loop of the c-Abl tyrosine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403040

Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403040

BCR/ABL directly inhibits expression of SHIP, an SH2-containing polyinositol-5-phosphatase involved in the regulation of hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403040

Regulation of Bcr-Abl-induced SAP kinase activity and transformation by the SHPTP1 protein tyrosine phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403040

Protein Tyrosine Phosphatase 1B Antagonizes Signalling by Oncoprotein Tyrosine Kinase p210 bcr-abl In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403040

BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403040

Dual-specific Src and Abl kinase inhibitors, PP1 and CGP76030, inhibit growth and survival of cells expressing imatinib mesylate-resistant Bcr-Abl kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403040

Stat5 phosphorylation status and DNA-binding activity in the bovine and murine mammary glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403040

7 January 2021

Highly efficient green fluorescent protein-based kinase substrates

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403040

7 January 2021

Role of alpha1 acid glycoprotein in the in vivo resistance of human BCR-ABL( ) leukemic cells to the abl inhibitor STI571

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403040

7 January 2021

c-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403040

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403040

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12970766 AND SRC:MED&resulttype=core&format=json

Dimensions Publication ID

7 November 2019

1015210130

0 references

1 reference